Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.04 USD | +2.14% | -4.59% | +40.00% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.00% | 882M | |
+7.35% | 111B | |
+10.92% | 106B | |
-12.25% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.97% | 16.81B | |
+38.39% | 12.54B | |
-24.75% | 8.09B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- Wedbush Starts Immunome With Outperform Rating, $12 Price Target; Has Positive View for Early-Stage Pipeline of Targeted Cancer Therapies